Complex and controversial issues in locally advanced non-small cell lung carcinoma

Area of Science:

• Medical Oncology
• Radiation Oncology
• Thoracic Oncology

Background:

• Locally advanced non-small cell lung cancer (NSCLC) presents significant clinical challenges.
• While potentially curable, survival rates remain poor despite improvements.
• Concurrent chemoradiotherapy is the standard of care for eligible patients.

Purpose of the Study:

• To summarize treatment advances for locally advanced NSCLC over decades.
• To explore current controversies and future research directions.

Main Methods:

• Review of historical and current treatment strategies for locally advanced NSCLC.
• Analysis of survival data and treatment outcomes.
• Identification of promising areas for clinical and translational research.

Main Results:

• Concurrent chemoradiotherapy offers substantial local response and durable control for many patients.
• Despite local control, distant metastatic failure remains a primary cause of mortality.
• Survival rates have improved but are still suboptimal compared to other malignancies.

Conclusions:

• While chemoradiotherapy has improved outcomes, distant metastasis remains a critical unmet need.
• Future research should focus on novel systemic therapies, radiotherapy optimization, toxicity mitigation, and targeted agents.